Home Allergan Cost Synergies On Track For Large Upside
 

Keywords :   


Allergan Cost Synergies On Track For Large Upside

2015-03-15 01:50:25| Biotech - Topix.net

AGN is positioned well to take advantage of attractive industry growth; we believe management is conservative about its estimates on revenue projections. After the $66 billion dollar Activis and Allergan deal, post merger synergies will arise.

Tags: large track cost upside

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »